{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:33:48Z","timestamp":1773876828262,"version":"3.50.1"},"reference-count":30,"publisher":"International Union Against Tuberculosis and Lung Disease","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["public health action"],"accepted":{"date-parts":[[2025,12,25]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>SETTING<\/jats:title>\n                    <jats:p>Anti-retroviral treatment (ART) centres from eight districts of Sierra Leone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVES<\/jats:title>\n                    <jats:p>Among children and adolescents (0\u201319 years) registered for ART after January 2023 and currently on care, to assess i) viral load (VL) testing coverage and viral suppression, ii) turnaround time from sample collection to results, and iii) factors associated with not undergoing testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN<\/jats:title>\n                    <jats:p>A cohort study using programmatic data extracted from April to October 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Of 950 participants, 931 (98%) were eligible for VL testing (on ART for \u22656 months). Of the total participants, 286 (30%) underwent VL testing at least once (coverage), of which 247 (86%) had viral suppression. Median turnaround time was 36 days, ranging from 6 days in districts with centralised VL testing laboratory to 65 days in a district far from the central laboratory. Participants from ART centres situated in the Western Area Urban district (adjusted relative risk: 1.8, 95% confidence interval: 1.0\u20133.1) were at higher risk of not undergoing VL testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Although high viral suppression was appreciable, less than one third of children and adolescents underwent VL testing with a long turnaround time, delaying virological failure detection and appropriate care. The national AIDS control programme should decentralise VL testing and strengthen sample transportation to ensure equitable access.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5588\/pha.25.0053","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:09:03Z","timestamp":1773850143000},"page":"15-21","source":"Crossref","is-referenced-by-count":0,"title":["Viral load testing coverage and suppression rate among children and adolescents on ART in Sierra Leone"],"prefix":"10.5588","volume":"16","author":[{"given":"F.","family":"Kanu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lansana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mustapha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.K.","family":"Tabor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Thekkur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.F.","family":"Kamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.D.","family":"Fofanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"Kanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Sesay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.S.","family":"Turay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Koroma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.K.","family":"Lahai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Falama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Sesay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lakoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3554","published-online":{"date-parts":[[2026,3,1]]},"reference":[{"key":"2026031809085750000_16.1.15.1","unstructured":"World Health Organization . Global HIV programme: HIV data and statistics. Geneva: WHO, 2025."},{"key":"2026031809085750000_16.1.15.2","unstructured":"UNICEF . HIV statistics - global and regional trends - although strides have been made in the HIV response, children are still affected by the epidemic, 2025."},{"key":"2026031809085750000_16.1.15.3","unstructured":"World Health Organization . HIV and AIDS. Geneva: WHO, 2025."},{"key":"2026031809085750000_16.1.15.4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272405"},{"key":"2026031809085750000_16.1.15.5","unstructured":"World Health Organization . Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: WHO, 2021."},{"issue":"8","key":"2026031809085750000_16.1.15.6","doi-asserted-by":"crossref","first-page":"e0003513","DOI":"10.1371\/journal.pgph.0003513","article-title":"Pediatric and adolescent HIV viral load coverage and suppression rates in the context of the COVID-19 pandemic in 12 PEPFAR-supported Sub-Saharan African countries in 2019 and 2020","volume":"4","author":"Carpenter","year":"2024","journal-title":"PLoS Glob Pub Health"},{"key":"2026031809085750000_16.1.15.7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jia2.25001","article-title":"Routine viral load monitoring in HIV-infected infants and children in low- and middle-income countries: challenges and opportunities: challenges","volume":"20","author":"Arpadi","year":"2017","journal-title":"J Int AIDS Soc"},{"key":"2026031809085750000_16.1.15.8","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2015.1058896"},{"issue":"12","key":"2026031809085750000_16.1.15.9","doi-asserted-by":"crossref","first-page":"e766","DOI":"10.1016\/S2352-3018(21)00265-4","article-title":"Global estimates of viral suppression in children\/adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multi-regional study from 31 countries","volume":"8","author":"Han","year":"2021","journal-title":"Lancet HIV"},{"issue":"1","key":"2026031809085750000_16.1.15.10","doi-asserted-by":"crossref","first-page":"e0316399","DOI":"10.1371\/journal.pone.0316399","article-title":"HIV viral load suppression rates among adults and children living with HIV in the North West Region of Cameroon: a call for action!","volume":"20","author":"Tayong","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"2026031809085750000_16.1.15.11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12985-023-02245-2","article-title":"HIV viral suppression at different thresholds and duration of treatment in the dolutegravir treatment era in Sierra Leone: a nationwide survey","volume":"20","author":"Song","year":"2023","journal-title":"Virol J"},{"key":"2026031809085750000_16.1.15.12","unstructured":"UNAIDS . \u201cSierra Leone.\u201d Geneva: Joint United Nations Programme on HIV\/AIDS, 2024. https:\/\/www.unaids.org\/en\/regionscountries\/countries\/sierraleone."},{"key":"2026031809085750000_16.1.15.13","unstructured":"National AIDS Control Programme, Ministry of Health, Government of Sierra Leone . National pediatric and adolescent HIV care toolkit: minimum package of care for integrated maternal, infant, child, and adolescent health in Sierra Leone. Sierra Leone Ministry Health: Freetown, Sierra Leone, 2024."},{"issue":"10409","key":"2026031809085750000_16.1.15.14","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(23)01788-9","article-title":"Call to action: HIV among adolescents in Sierra Leone","volume":"402","author":"Baldeh","year":"2023","journal-title":"Lancet"},{"key":"2026031809085750000_16.1.15.15","first-page":"1","article-title":"Prevalence and factors associated with advanced HIV disease among young people aged 15 \u2013 24 years in a national referral hospital in Sierra Leone: a cross-sectional study","volume":"2023","author":"Baldeh","year":"2023","journal-title":"medRxiv"},{"key":"2026031809085750000_16.1.15.16","unstructured":"US Centres for Disease Control and Prevention . HIV and TB overview: Sierra Leone. Atlanta, GA, USA: CDC, 2025."},{"key":"2026031809085750000_16.1.15.17","unstructured":"Institute for Health Metrics and Evaluation . Sierra Leone population and housing census 2015. Seattle, WA, USA: Institute for Health Metrics and Evaluation (IHME), 2015."},{"key":"2026031809085750000_16.1.15.18","unstructured":"Ministry of Health and Sanitation . Sierra Leone basic package of essential health services. Freetown, Sierra Leone: Ministry of Health and Sanitation, 2015."},{"key":"2026031809085750000_16.1.15.19","unstructured":"United Nations . Sustainable development goals [internet]. New York, NY, USA: United Nations, 2015."},{"key":"2026031809085750000_16.1.15.20","unstructured":"United National General Assembly . Political declaration on HIV and AIDS: ending inequalities and getting on track to end AIDS by 2030. Geneva: WHO, 2021."},{"issue":"6","key":"2026031809085750000_16.1.15.21","doi-asserted-by":"crossref","first-page":"e0275560","DOI":"10.1371\/journal.pone.0275560","article-title":"The epidemiology of HIV population viral load in twelve sub-Saharan African countries","volume":"18","author":"Hladik","year":"2023","journal-title":"PLoS One"},{"key":"2026031809085750000_16.1.15.22","doi-asserted-by":"crossref","first-page":"1565242","DOI":"10.3389\/fpubh.2025.1565242","article-title":"Considerable variation in the 95-95-95 targets accomplishment between children and adults might delay achievement of set targets","volume":"13","author":"Kulohoma","year":"2025","journal-title":"Front Public Health"},{"issue":"5","key":"2026031809085750000_16.1.15.23","doi-asserted-by":"crossref","first-page":"e0004510","DOI":"10.1371\/journal.pgph.0004510","article-title":"Barriers to viral suppression in children aged 9 years or younger on dolutegravir-based antiretroviral therapy in Malawi, a mixed-methods study","volume":"5","author":"Phiri","year":"2025","journal-title":"PLoS Glob Pub Health"},{"key":"2026031809085750000_16.1.15.24","doi-asserted-by":"crossref","first-page":"1487302","DOI":"10.3389\/fpubh.2025.1487302","article-title":"Assessing the effects of the COVID-19 pandemic on new ART initiation and viral load access among children and adolescents living with HIV in West Africa: an interrupted time series analysis","volume":"13","author":"Konu","year":"2025","journal-title":"Front Pub Health"},{"key":"2026031809085750000_16.1.15.25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-083206"},{"key":"2026031809085750000_16.1.15.26","doi-asserted-by":"crossref","first-page":"1609743","DOI":"10.3389\/fpubh.2025.1609743","article-title":"Barriers to ART adherence in sub-Saharan Africa: a scoping review toward achieving UNAIDS 95-95-95 targets","volume":"13","author":"Magura","year":"2025","journal-title":"Front Pub Health"},{"key":"2026031809085750000_16.1.15.27","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.12.25323867"},{"issue":"1","key":"2026031809085750000_16.1.15.28","first-page":"629","article-title":"Viral load non-suppression among adolescents and youth living with HIV in South Africa","volume":"39","author":"Molopa","year":"2024","journal-title":"South Afr J Infect Dis"},{"issue":"8","key":"2026031809085750000_16.1.15.29","doi-asserted-by":"crossref","first-page":"105185","DOI":"10.1016\/j.idnow.2025.105185","article-title":"Efficacy of dolutegravir-based regimen in HIV-infected children in a treatment center in a regional health facility in Cameroon","volume":"55","author":"Chiabi","year":"2025","journal-title":"Infect Dis Now"},{"key":"2026031809085750000_16.1.15.30","doi-asserted-by":"crossref","first-page":"100573","DOI":"10.1016\/j.eclinm.2020.100573","article-title":"Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: a systematic literature review and network meta-analysis","volume":"28","author":"Kanters","year":"2020","journal-title":"EClinicalMedicine"}],"container-title":["Public Health Action"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.5588\/pha.25.0053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:09:31Z","timestamp":1773850171000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.theunion.org\/lookup\/doi\/10.5588\/pha.25.0053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,1]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.5588\/pha.25.0053"],"URL":"https:\/\/doi.org\/10.5588\/pha.25.0053","relation":{},"ISSN":["2220-8372"],"issn-type":[{"value":"2220-8372","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}